These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9218156

  • 1. The place of myeloid growth factors in the treatment of hairy-cell leukaemia.
    Christopoulos C, Fortis A, Nikzas D, Anevlavis E.
    Clin Lab Haematol; 1997 Jun; 19(2):149-50. PubMed ID: 9218156
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of 2-chlorodeoxyadenosine, granulocyte-colony-stimulating factor, and erythropoietin in a Jehovah's Witness with hairy cell leukemia.
    Couban S, Wilson WE.
    Am J Hematol; 1995 Jul; 49(3):255-6. PubMed ID: 7541605
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ, Plard JP, Wells MY, Zerial A, Roquet F.
    Cancer Chemother Pharmacol; 1997 Jul; 39(3):259-66. PubMed ID: 8996530
    [Abstract] [Full Text] [Related]

  • 9. Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.
    Gisselbrecht C, Haioun C, Lepage E, Bastion Y, Tilly H, Bosly A, Dupriez B, Marit G, Herbrecht R, Deconinck E, Marolleau JP, Yver A, Dabouz-Harrouche F, Coiffier B, Reyes F.
    Leuk Lymphoma; 1997 Apr; 25(3-4):289-300. PubMed ID: 9168439
    [Abstract] [Full Text] [Related]

  • 10. Use of recombinant granulocyte-colony stimulating factor to treat neutropenia occurring during craniospinal irradiation.
    Mac Manus MP, Clarke J, McCormick D, Abram WP.
    Int J Radiat Oncol Biol Phys; 1993 Aug 01; 26(5):845-50. PubMed ID: 7688362
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
    Takeshita A, Saito H, Toyama K, Horiuchi A, Kuriya S, Furusawa S, Tsuruoka N, Takiguchi T, Matsuda T, Utsumi M, Shiku H, Matsui T, Egami K, Tamura K, Ohno R.
    Int J Hematol; 2000 Feb 01; 71(2):136-43. PubMed ID: 10745623
    [Abstract] [Full Text] [Related]

  • 12. Delayed response to granulocyte colony-stimulating factor (G-CSF) in a case of severe neutropenia associated with large granular lymphocyte (LGL) leukemia.
    Genvresse I, Späth-Schwalbe E, Lukowsky A, Possinger K.
    Eur J Haematol; 1998 Feb 01; 60(2):133-4. PubMed ID: 9508355
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of hair cell leukemia with 2-chlorodeoxyadenosine and G-CSF].
    Bengió R, Pérez M, Sarmiento M, Raña P, Sánchez Lucero A, Sarto A, Arrossagaray G.
    Medicina (B Aires); 1996 Feb 01; 56(5 Pt 1):534. PubMed ID: 9239892
    [No Abstract] [Full Text] [Related]

  • 14. Successful treatment of chronic idiopathic neutropenia using recombinant granulocyte colony-stimulating factor.
    Furukawa T, Takahashi M, Moriyama Y, Koike T, Kurokawa I, Shibata A.
    Ann Hematol; 1991 Feb 01; 62(1):22-4. PubMed ID: 1709572
    [Abstract] [Full Text] [Related]

  • 15. [Acute myeloic leukemia: evaluation of colony-stimulating factors].
    Hiddemann W.
    Dtsch Med Wochenschr; 2012 Nov 01; 137(45):2306. PubMed ID: 23111791
    [No Abstract] [Full Text] [Related]

  • 16. Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation.
    Gisselbrecht C, Prentice HG, Bacigalupo A, Biron P, Milpied N, Rubie H, Cunningham D, Legros M, Pico JL, Linch DC.
    Lancet; 1994 Mar 19; 343(8899):696-700. PubMed ID: 7510813
    [Abstract] [Full Text] [Related]

  • 17. Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia.
    Bradstock K, Matthews J, Young G, Lowenthal R, Baxter H, Arthur C, Bashford J, Brighton T, Cannell P, Dunlop L, Durrant S, Enno A, Eliadis P, Gill D, Gillett A, Gottlieb D, Januszewicz H, Joshua D, Leahy M, Schwarer A, Taylor K, Australian Leukaemia Study Group.
    Leukemia; 2001 Sep 19; 15(9):1331-8. PubMed ID: 11516093
    [Abstract] [Full Text] [Related]

  • 18. Recombinant human granulocyte colony-stimulating factor therapy for cyclic neutropenia associated with common variable immunodeficiency.
    Tsuda M, Urakami T, Watanabe S, Shimizu H, Inana I, Kikkawa Y, Kitagawa T.
    Acta Paediatr Jpn; 1993 Apr 19; 35(2):124-6. PubMed ID: 7684881
    [Abstract] [Full Text] [Related]

  • 19. Granulocyte colony-stimulating factor for neutropenia secondary to ticlopidine.
    Ruiz-Irastorza G, Alonso JJ, Iglesias JJ, Aguirre C.
    Acta Haematol; 1994 Apr 19; 91(2):106-7. PubMed ID: 7517606
    [No Abstract] [Full Text] [Related]

  • 20. Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings.
    Frampton JE, Yarker YE, Goa KL.
    Drugs; 1995 May 19; 49(5):767-93. PubMed ID: 7541335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.